You are here

antibodies

Genmab expands its pipeline with $630m Scancell deal

Pharmaphorum

Wed, 12/4/24 - 10:01 am

Sanofi readies to meet US demand for RSV antibody

BioPharma Dive

Mon, 09/16/24 - 10:17 pm

Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push

Fierce Biotech

Thu, 08/22/24 - 11:55 am

Oblique Therapeutics

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer

BioSpace

Mon, 04/22/24 - 11:27 am

Evotec Biologics expands partnership with ABL to develop antibodies against HIV

Biopharma Reporter

Mon, 02/12/24 - 11:10 pm

Evotec Biologics

Immunovant shares surge as early antibody treatment data beats expectations

Yahoo/Reuters

Tue, 09/26/23 - 11:43 am

clinical trials

autoimmune diseases

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement

Fierce Pharma

Mon, 09/18/23 - 12:30 pm

Samsung BioLogics

Bristol Myers Squibb

drug manufacturing

After Catalent rumors, Danaher strikes $5.7B deal to acquire antibody specialist Abcam

Fierce Pharma

Mon, 08/28/23 - 12:00 pm

Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm

BioSpace

Fri, 05/12/23 - 10:16 am

clinical trials

AstraZeneca confident new COVID antibody protects against known variants

Reuters

Wed, 04/19/23 - 10:30 am

FDA starts review of Sanofi, AZ antibody for RSV prevention

Pharmaphorum

Thu, 01/5/23 - 10:20 am

AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy

BioSpace

Thu, 10/20/22 - 11:29 pm

pulmonary fibrosis

Versant partners with AbCellera to arm startups with better antibodies

BioPharma Dive

Wed, 07/27/22 - 10:45 am

Versant Ventures

drug development

AstraZeneca picks up suite of new Covid-19 antibodies, shining spotlight on Oxford-tied startup

Endpoints

Tue, 05/17/22 - 10:36 am

RQ Biotechnology

Astellas, Twist Join Forces to Enhance Tumor Immunity

BioSpace

Tue, 05/10/22 - 10:38 pm

Twist Bioscience

AstraZeneca says no severe virus cases or deaths after taking antibody

Morningstar

Thu, 04/21/22 - 10:51 am

Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review

Fierce Pharma

Thu, 04/14/22 - 10:56 am

FDA halts Vir, GSK antibody use in response to COVID subvariant's spread

BioPharma Dive

Wed, 04/6/22 - 12:28 pm

Vir Biotechnology

First-Ever Computationally-Designed Antibody Enters Clinical Trials

BioSpace

Tue, 04/5/22 - 11:35 pm

Biolojic Design

clinical trials

Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?

Fierce Biotech

Wed, 03/30/22 - 10:55 am

Adagio Therapeutics

Pages